Renal Disease in Cardiovascular Disorders: An Underrecognized Problem
Authors:
- Eric BruckertEBEric Bruckert
- Corinne BagnisCBCorinne Bagnis
- Gilbert DerayGDGilbert Deray
- 1 April 2005
- journal article
- review article
- Published by S. Karger AG in American Journal of Nephrology
- Vol. 25 (2) , 95-105
Abstract
Chronic renal disease is generally appreciated as a major and rapidly growing health problem. In the United States alone, as many as 19.5 million people may have markers of early renal disease, and more than 660,000 people are expected to require renal replacement therapy by the year 2010. By contrast, the presence and pathological role of renal disease in patients with cardiovascular disease are somewhat underrecognized. Evidence now shows that even minor impairments in renal function, as indicated by measures including glomerular filtration rate and microalbuminuria, are common in cardiovascular disease states and predictive of cardiovascular events. Indeed, microalbuminuria may be a marker of systemic vascular disease rather than kidney dysfunction alone. In patients with hypertension, diabetes, metabolic syndrome, acute coronary syndromes, and stroke, markers of renal disease have proved to be at least as predictive of morbidity and mortality as conventional risk factors. Yet, chart reviews in a variety of clinical settings reflect poor recognition and management of renal disease in at-risk patients. Models for renal protection are based on the control of risk factors, particularly blood pressure, that are associated with renal and cardiovascular outcomes. Screening protocols for markers of renal disease should recognize the potential inaccuracy of serum creatinine concentrations and the preferability of glomerular filtration rate estimates that take age and gender into account. Pilot programs for screening high-risk populations have shown efficacy in detecting renal disease.Keywords
This publication has 59 references indexed in Scilit:
- Management of hypertension and screening of renal complications by GPs in diabetic type 2 patients (France — 2001)Diabetes & Metabolism, 2003
- Does Renal Dysfunction Predict Mortality After Acute Stroke?Stroke, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Effect of lipid reduction on the progression of renal disease: A meta-analysisKidney International, 2001
- Plasma lipids and risk of developing renal dysfunction: The Atherosclerosis Risk in Communities StudyKidney International, 2000
- Urinary albumin and insulin as predictors of coronary artery disease: An angiographic studyAmerican Journal of Kidney Diseases, 1999
- Screening and management of microalbuminuria in patients with diabetes mellitus: recommendations to the scientific advisory board of the nationals Kidney Foundation from an Ad Hoc Committee of the council on diabetes mel of the national kidney foundationAmerican Journal of Kidney Diseases, 1995
- The prognostic significance of proteinuria: The Framingham studyAmerican Heart Journal, 1984
- Microalbuminuria Predicts Clinical Proteinuria and Early Mortality in Maturity-Onset DiabetesNew England Journal of Medicine, 1984
- Hypertensive vascular disease; description and natural historyJournal of Chronic Diseases, 1955